<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Biosyent Inc. — News on 6ix</title>
    <link>https://6ix.com/company/biosyent-inc</link>
    <description>Latest news and press releases for Biosyent Inc. on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 15 Apr 2026 12:40:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/biosyent-inc" rel="self" type="application/rss+xml" />
    <item>
      <title>BioSyent to Present at 2026 Bloom Burton &amp; Co. Healthcare Investor Conference</title>
      <link>https://6ix.com/company/biosyent-inc/news/biosyent-to-present-at-2026-bloom-burton-and-co-healthcare-investor-conference</link>
      <guid isPermaLink="true">https://6ix.com/company/biosyent-inc/news/biosyent-to-present-at-2026-bloom-burton-and-co-healthcare-investor-conference</guid>
      <pubDate>Wed, 15 Apr 2026 12:40:00 GMT</pubDate>
      <description>MISSISSAUGA, Ontario, April 15, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (&amp;#x201C;BioSyent&amp;#x201D;,...</description>
    </item>
    <item>
      <title>FeraMAX is Canada&apos;s Top-Ranked Iron Supplement for 11 Consecutive Years</title>
      <link>https://6ix.com/company/biosyent-inc/news/feramax-is-canadas-top-ranked-iron-supplement-for-11-consecutive-years</link>
      <guid isPermaLink="true">https://6ix.com/company/biosyent-inc/news/feramax-is-canadas-top-ranked-iron-supplement-for-11-consecutive-years</guid>
      <pubDate>Wed, 01 Apr 2026 12:30:00 GMT</pubDate>
      <description>MISSISSAUGA, Ontario, April 01, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (&amp;#x201C;BioSyent&amp;#x201D;,...</description>
    </item>
    <item>
      <title>BioSyent Releases Financial Results for Fourth Quarter and Full Year 2025</title>
      <link>https://6ix.com/company/biosyent-inc/news/biosyent-releases-financial-results-for-fourth-quarter-and-full-year-2025</link>
      <guid isPermaLink="true">https://6ix.com/company/biosyent-inc/news/biosyent-releases-financial-results-for-fourth-quarter-and-full-year-2025</guid>
      <pubDate>Thu, 19 Mar 2026 21:30:00 GMT</pubDate>
      <description>MISSISSAUGA, Ontario, March 19, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (&amp;#x201C;BioSyent&amp;#x201D;,...</description>
    </item>
    <item>
      <title>BioSyent Schedules Fourth Quarter and Full Year 2025 Earnings Release for March 19, 2026</title>
      <link>https://6ix.com/company/biosyent-inc/news/biosyent-schedules-fourth-quarter-and-full-year-2025-earnings-release-for-march-19-2026</link>
      <guid isPermaLink="true">https://6ix.com/company/biosyent-inc/news/biosyent-schedules-fourth-quarter-and-full-year-2025-earnings-release-for-march-19-2026</guid>
      <pubDate>Thu, 12 Mar 2026 21:30:00 GMT</pubDate>
      <description>MISSISSAUGA, Ontario, March 12, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the fourth quarter and full year ended December 31, 2025 on Thursday, March 19, 2026 after market hours. A presentation on the Company’s fourth quarter and full year 2025 results by René Goehrum, BioSyent President and CEO, will also be available on the Company’s website on the date of release. About BioSyent Inc. Listed on the TSX Ventur</description>
    </item>
    <item>
      <title>BioSyent Announces Closing of the Acquisition of Oral Science Inc.</title>
      <link>https://6ix.com/company/biosyent-inc/news/biosyent-announces-closing-of-the-acquisition-of-oral-science-inc</link>
      <guid isPermaLink="true">https://6ix.com/company/biosyent-inc/news/biosyent-announces-closing-of-the-acquisition-of-oral-science-inc</guid>
      <pubDate>Mon, 02 Mar 2026 13:30:00 GMT</pubDate>
      <description>MISSISSAUGA, Ontario, March 02, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture (TSXV): RX) is pleased to announce that it has successfully closed the previously-announced acquisition of Oral Science Inc. (“Oral Science”), a privately-owned Canadian distributor of specialized healthcare products for dental hygiene and oral health based in Brossard, Quebec. Pursuant to the terms of a Share Purchase Agreement (“SPA”) dated February 8, 2026, BioSyent, through its wholly-owned subsid</description>
    </item>
    <item>
      <title>BioSyent to Acquire Oral Science Inc.</title>
      <link>https://6ix.com/company/biosyent-inc/news/biosyent-acquire-oral-science-inc-123000809</link>
      <guid isPermaLink="true">https://6ix.com/company/biosyent-inc/news/biosyent-acquire-oral-science-inc-123000809</guid>
      <pubDate>Mon, 09 Feb 2026 12:30:00 GMT</pubDate>
      <description>Accretive Transaction with Combined Companies’ Pro-Forma Revenue in Excess of $70.00 Million and EBITDA(1) in Excess of $15.75 Million (TTM Sept 30, 2025) MISSISSAUGA, Ontario, Feb. 09, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture (TSXV): RX) announced today that it has entered into a Share Purchase Agreement (“SPA”) dated February 8, 2026 to acquire Oral Science Inc. (“Oral Science”), a privately-owned Canadian distributor of specialized healthcare products for dental hygiene</description>
    </item>
    <item>
      <title>BioSyent Declares First Quarter 2026 Dividend</title>
      <link>https://6ix.com/company/biosyent-inc/news/biosyent-declares-first-quarter-2026-213000417</link>
      <guid isPermaLink="true">https://6ix.com/company/biosyent-inc/news/biosyent-declares-first-quarter-2026-213000417</guid>
      <pubDate>Thu, 29 Jan 2026 21:30:00 GMT</pubDate>
      <description>MISSISSAUGA, Ontario, Jan. 29, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.055 per common share, payable in Canadian Dollars on March 13, 2026, to shareholders of record at the close of business on February 27, 2026. This first quarter 2026 dividend represents a 10% increase from the fourth quarter 2025 dividend of $0.05 per common share. This dividend qualifies as a</description>
    </item>
    <item>
      <title>BioSyent Announces Renewal of Normal Course Issuer Bid</title>
      <link>https://6ix.com/company/biosyent-inc/news/biosyent-announces-renewal-of-normal-course-issuer-bid</link>
      <guid isPermaLink="true">https://6ix.com/company/biosyent-inc/news/biosyent-announces-renewal-of-normal-course-issuer-bid</guid>
      <pubDate>Mon, 15 Dec 2025 21:30:00 GMT</pubDate>
      <description>MISSISSAUGA, Ontario, Dec. 15, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (&amp;#x201C;BioSyent&amp;#x201D;, ...</description>
    </item>
    <item>
      <title>BioSyent Releases Financial Results for Q3 and YTD 2025</title>
      <link>https://6ix.com/company/biosyent-inc/news/biosyent-releases-financial-results-for-q3-and-ytd-2025</link>
      <guid isPermaLink="true">https://6ix.com/company/biosyent-inc/news/biosyent-releases-financial-results-for-q3-and-ytd-2025</guid>
      <pubDate>Thu, 20 Nov 2025 22:30:00 GMT</pubDate>
      <description>MISSISSAUGA, Ontario, Nov. 20, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (&amp;#x201C;BioSyent&amp;#x201D;, ...</description>
    </item>
    <item>
      <title>BioSyent Declares Fourth Quarter 2025 Dividend</title>
      <link>https://6ix.com/company/biosyent-inc/news/biosyent-declares-fourth-quarter-2025-dividend</link>
      <guid isPermaLink="true">https://6ix.com/company/biosyent-inc/news/biosyent-declares-fourth-quarter-2025-dividend</guid>
      <pubDate>Thu, 20 Nov 2025 22:29:00 GMT</pubDate>
      <description>MISSISSAUGA, Ontario, Nov. 20, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (&amp;#x201C;BioSyent&amp;#x201D;, ...</description>
    </item>
    <item>
      <title>BioSyent Schedules Q3 and YTD 2025 Earnings Release for November 20, 2025</title>
      <link>https://6ix.com/company/biosyent-inc/news/biosyent-schedules-q3-and-ytd-2025-earnings-release-for-november-20-2025</link>
      <guid isPermaLink="true">https://6ix.com/company/biosyent-inc/news/biosyent-schedules-q3-and-ytd-2025-earnings-release-for-november-20-2025</guid>
      <pubDate>Thu, 13 Nov 2025 21:05:00 GMT</pubDate>
      <description>MISSISSAUGA, Ontario, Nov. 13, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (&amp;#x201C;BioSyent&amp;#x201D;, ...</description>
    </item>
    <item>
      <title>BioSyent Releases Financial Results for Q2 and H1 2025</title>
      <link>https://6ix.com/company/biosyent-inc/news/biosyent-releases-financial-results-for-q2-and-h1-2025</link>
      <guid isPermaLink="true">https://6ix.com/company/biosyent-inc/news/biosyent-releases-financial-results-for-q2-and-h1-2025</guid>
      <pubDate>Thu, 21 Aug 2025 20:45:00 GMT</pubDate>
      <description>MISSISSAUGA, Ontario, Aug. 21, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (&amp;#x201C;BioSyent&amp;#x201D;, ...</description>
    </item>
    <item>
      <title>BioSyent Declares Third Quarter 2025 Dividend</title>
      <link>https://6ix.com/company/biosyent-inc/news/biosyent-declares-third-quarter-2025-dividend</link>
      <guid isPermaLink="true">https://6ix.com/company/biosyent-inc/news/biosyent-declares-third-quarter-2025-dividend</guid>
      <pubDate>Thu, 21 Aug 2025 20:43:00 GMT</pubDate>
      <description>MISSISSAUGA, Ontario, Aug. 21, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (&amp;#x201C;BioSyent&amp;#x201D;, ...</description>
    </item>
    <item>
      <title>BioSyent Schedules Q2 and H1 2025 Earnings Release for August 21, 2025</title>
      <link>https://6ix.com/company/biosyent-inc/news/biosyent-schedules-q2-and-h1-2025-earnings-release-for-august-21-2025</link>
      <guid isPermaLink="true">https://6ix.com/company/biosyent-inc/news/biosyent-schedules-q2-and-h1-2025-earnings-release-for-august-21-2025</guid>
      <pubDate>Thu, 14 Aug 2025 21:00:00 GMT</pubDate>
      <description>MISSISSAUGA, Ontario, Aug. 14, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (&amp;#x201C;BioSyent&amp;#x201D;, ...</description>
    </item>
    <item>
      <title>BioSyent Releases Financial Results for First Quarter 2025</title>
      <link>https://6ix.com/company/biosyent-inc/news/biosyent-releases-financial-results-for-first-quarter-2025</link>
      <guid isPermaLink="true">https://6ix.com/company/biosyent-inc/news/biosyent-releases-financial-results-for-first-quarter-2025</guid>
      <pubDate>Thu, 15 May 2025 21:45:00 GMT</pubDate>
      <description>MISSISSAUGA, Ontario, May 15, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (&amp;#x201C;BioSyent&amp;#x201D;, T...</description>
    </item>
    <item>
      <title>BioSyent Declares Second Quarter 2025 Dividend</title>
      <link>https://6ix.com/company/biosyent-inc/news/biosyent-declares-second-quarter-2025-dividend</link>
      <guid isPermaLink="true">https://6ix.com/company/biosyent-inc/news/biosyent-declares-second-quarter-2025-dividend</guid>
      <pubDate>Thu, 15 May 2025 21:44:00 GMT</pubDate>
      <description>MISSISSAUGA, Ontario, May 15, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (&amp;#x201C;BioSyent&amp;#x201D;, &amp;...</description>
    </item>
    <item>
      <title>BioSyent Schedules First Quarter Earnings Release for May 15, 2025</title>
      <link>https://6ix.com/company/biosyent-inc/news/biosyent-schedules-first-quarter-earnings-release-for-may-15-2025</link>
      <guid isPermaLink="true">https://6ix.com/company/biosyent-inc/news/biosyent-schedules-first-quarter-earnings-release-for-may-15-2025</guid>
      <pubDate>Thu, 08 May 2025 20:30:00 GMT</pubDate>
      <description>MISSISSAUGA, Ontario, May 08, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (&amp;#x201C;BioSyent&amp;#x201D;, &amp;...</description>
    </item>
    <item>
      <title>BioSyent to Present at 2025 Bloom Burton &amp; Co. Healthcare Investor Conference</title>
      <link>https://6ix.com/company/biosyent-inc/news/biosyent-to-present-at-2025-bloom-burton-and-co-healthcare-investor-conference</link>
      <guid isPermaLink="true">https://6ix.com/company/biosyent-inc/news/biosyent-to-present-at-2025-bloom-burton-and-co-healthcare-investor-conference</guid>
      <pubDate>Wed, 30 Apr 2025 13:25:00 GMT</pubDate>
      <description>MISSISSAUGA, Ontario, April 30, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (&amp;#x201C;BioSyent&amp;#x201D;,...</description>
    </item>
    <item>
      <title>BioSyent to Attend Planet MicroCap Showcase</title>
      <link>https://6ix.com/company/biosyent-inc/news/biosyent-to-attend-planet-microcap-showcase</link>
      <guid isPermaLink="true">https://6ix.com/company/biosyent-inc/news/biosyent-to-attend-planet-microcap-showcase</guid>
      <pubDate>Mon, 14 Apr 2025 21:30:00 GMT</pubDate>
      <description>MISSISSAUGA, Ontario, April 14, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (&amp;#x201C;BioSyent&amp;#x201D;,...</description>
    </item>
    <item>
      <title>BioSyent to Present at LD Micro New York Investor Conference</title>
      <link>https://6ix.com/company/biosyent-inc/news/biosyent-to-present-at-ld-micro-new-york-investor-conference</link>
      <guid isPermaLink="true">https://6ix.com/company/biosyent-inc/news/biosyent-to-present-at-ld-micro-new-york-investor-conference</guid>
      <pubDate>Fri, 04 Apr 2025 21:00:00 GMT</pubDate>
      <description>Mississauga, Ontario--(Newsfile Corp. - April 4, 2025) - BioSyent Inc. (TSXV: RX) (&quot;BioSyent&quot; or ...</description>
    </item>
  </channel>
</rss>